New price cap on stents limits margins to 8 percent; DES price comes down to Rs 28,000
The price cap is aimed at preventing "exploitative pricing, unethical profiteering and an extraordinary failed market system", the National Pharmaceutical Pricing Authority said.
Feb 13, 2018, 09:22 AM IST